| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report
|
Zhang, Jian-hui
|
|
|
103 |
5 |
p. 1765-1774
|
article
|
| 2 |
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature
|
Mercadal, Santiago
|
|
|
103 |
5 |
p. 1717-1727
|
article
|
| 3 |
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation
|
Takemura, Kazuya
|
|
|
103 |
5 |
p. 1705-1715
|
article
|
| 4 |
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century
|
Bei, Li-Ye
|
|
|
103 |
5 |
p. 1675-1685
|
article
|
| 5 |
Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation
|
Tian, Zhengqin
|
|
|
103 |
5 |
p. 1729-1736
|
article
|
| 6 |
Concomitant large deletion and de novo duplication of factor VIII gene in an Indian patient with severe Hemophilia A
|
Ray, Debadrita
|
|
|
103 |
5 |
p. 1789-1790
|
article
|
| 7 |
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia
|
Schlosser, Pascal
|
|
|
103 |
5 |
p. 1613-1622
|
article
|
| 8 |
Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia
|
Chen, Yue
|
|
|
103 |
5 |
p. 1801
|
article
|
| 9 |
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
|
Röth, Alexander
|
|
|
103 |
5 |
p. 1803
|
article
|
| 10 |
COVID-19 and β-thalassemia: in lieu of evidence and vague nexus
|
Al-Kuraishy, Hayder M.
|
|
|
103 |
5 |
p. 1423-1433
|
article
|
| 11 |
Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance
|
Cui, Sha
|
|
|
103 |
5 |
p. 1665-1673
|
article
|
| 12 |
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
|
Shumilov, Evgenii
|
|
|
103 |
5 |
p. 1587-1599
|
article
|
| 13 |
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report
|
Kurosawa, Shuhei
|
|
|
103 |
5 |
p. 1779-1781
|
article
|
| 14 |
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization
|
Hou, Li-qiong
|
|
|
103 |
5 |
p. 1601-1611
|
article
|
| 15 |
Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract
|
Xie, Rongli
|
|
|
103 |
5 |
p. 1687-1695
|
article
|
| 16 |
Epigenetic alterations and advancement of lymphoma treatment
|
Zhuang, Shuhui
|
|
|
103 |
5 |
p. 1435-1454
|
article
|
| 17 |
Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report
|
Wang, Jiawen
|
|
|
103 |
5 |
p. 1775-1777
|
article
|
| 18 |
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation
|
Zhou, Miao
|
|
|
103 |
5 |
p. 1697-1704
|
article
|
| 19 |
How to improve RCHOP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of 21 randomized controlled trials
|
Intzes, Stergios
|
|
|
103 |
5 |
p. 1623-1633
|
article
|
| 20 |
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma
|
Qi, Fei
|
|
|
103 |
5 |
p. 1643-1653
|
article
|
| 21 |
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation
|
Umezawa, Yoshihiro
|
|
|
103 |
5 |
p. 1737-1744
|
article
|
| 22 |
Is eryptosis druggable?
|
Tkachenko, Anton
|
|
|
103 |
5 |
p. 1791-1792
|
article
|
| 23 |
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape
|
Fontana, Diletta
|
|
|
103 |
5 |
p. 1561-1568
|
article
|
| 24 |
Loeys-Dietz syndrome with concomitant aplastic anemia
|
Zha, Qiang
|
|
|
103 |
5 |
p. 1793-1795
|
article
|
| 25 |
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways
|
Rahmati, Atefe
|
|
|
103 |
5 |
p. 1455-1482
|
article
|
| 26 |
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects
|
Zangi, Ali Rajabi
|
|
|
103 |
5 |
p. 1493-1511
|
article
|
| 27 |
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives
|
Krecak, Ivan
|
|
|
103 |
5 |
p. 1513-1523
|
article
|
| 28 |
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians
|
Gebel, Cordula
|
|
|
103 |
5 |
p. 1753-1763
|
article
|
| 29 |
Posttransplant cyclophosphamide beyond haploidentical transplantation
|
Arcuri, Leonardo Javier
|
|
|
103 |
5 |
p. 1483-1491
|
article
|
| 30 |
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
|
Murru, Roberta
|
|
|
103 |
5 |
p. 1655-1664
|
article
|
| 31 |
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage
|
Suárez, Edwin Uriel
|
|
|
103 |
5 |
p. 1797-1799
|
article
|
| 32 |
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection
|
Li, Yuanfang
|
|
|
103 |
5 |
p. 1541-1547
|
article
|
| 33 |
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia
|
Bardón-Cancho, Eduardo J.
|
|
|
103 |
5 |
p. 1525-1539
|
article
|
| 34 |
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices
|
Franke, Georg-Nikolaus
|
|
|
103 |
5 |
p. 1569-1575
|
article
|
| 35 |
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study
|
Fu, Haixia
|
|
|
103 |
5 |
p. 1549-1559
|
article
|
| 36 |
The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms
|
Holik, Hrvoje
|
|
|
103 |
5 |
p. 1783-1785
|
article
|
| 37 |
The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients
|
Wu, Chia-Ying
|
|
|
103 |
5 |
p. 1577-1586
|
article
|
| 38 |
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population
|
Gill, Emily L.
|
|
|
103 |
5 |
p. 1745-1752
|
article
|
| 39 |
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
|
Qin, Shuchao
|
|
|
103 |
5 |
p. 1635-1642
|
article
|
| 40 |
Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?
|
Niscola, Pasquale
|
|
|
103 |
5 |
p. 1787-1788
|
article
|
Journal description